Wang XF, Wu YH, Wang MS, Wang YS. CEA, AFP, CA125, CA153 and CA199 in malignant pleural effusions predict the cause. Asian Pac J Cancer Prev. 2014;15(1):363–8.
Porcel JM, Gasol A, Bielsa S, Civit C, Light RW, Salud A. Clinical features and survival of lung cancer patients with pleural effusions. Respirology. 2015;20(4):654–9.
Xu C, Qian L, Yu L, Zhang X, Wang Q. Evaluation of serum and pleural levels of soluble B7–H4 in lung cancer patients with pleural effusion. Biomarkers. 2015;20(4):271–4.
Xu C, Yu L, Zhan P, Zhang Y. Elevated pleural effusion IL-17 is a diagnostic marker and outcome predictor in lung cancer patients. Eur J Med Res. 2014;19(1):23.
Kaul V, McCracken DJ, Rahman NM, Epelbaum O. Contemporary approach to the diagnosis of malignant pleural effusion. Ann Am Thorac Soc. 2019;16(9):1099–106.
Trapé J, Molina R, Sant F, Montesinos J, Arnau A, Franquesa J, Blavia R, Martín E, Marquilles E, Perich D, Pérez C, Roca JM, Doménech M, López J, Badal JM. Diagnostic accuracy of tumour markers in serous effusions: a validation study. Tumour Biol. 2012;33(5):1661–8.
Hooper CE, Welham SA, Maskell NA; British Thoracic Society. Pleural procedures and patient safety: a national BTS audit of practice. Thorax. 2015; 70(2): 189–91.
Mazurek S, Boschek CB, Hugo F, Eigenbrodt E. Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol. 2005;15(4):300–8.
Ventrucci M, Cipolla A, Racchini C, Casadei R, Simoni P, Gullo L. Tumor M2-pyruvate kinase, a new metabolic marker for pancreatic cancer. Dig Dis Sci. 2004;49(7–8):1149–55.
Zhang B, Chen J, Chen D, Wang G, Shen P. Tumor type M2 pyruvate kinase expression in gastric cancer, colorectal cancer and controls. World J Gastroenterol. 2004;10(11):1643–6.
Shi HZ, Liang QL, Jiang J, Qin XJ, Yang HB. Diagnostic value of carcinoembryonic antigen in malignant pleural effusion: a meta-analysis. Respirology. 2008;13(4):518–27.
Hackner K, Errhalt P, Handzhiev S. Ratio of carcinoembryonic antigen in pleural fluid and serum for the diagnosis of malignant pleural effusion. Ther Adv Med Oncol. 2019;11:1758835919850341.
Zhang F, Hu L, Wang J, Chen J, Chen J, Wang Y. Clinical value of jointly detection serum lactate dehydrogenase/pleural fluid adenosine deaminase and pleural fluid carcinoembryonic antigen in the identification of malignant pleural effusion. J Clin Lab Anal. 2017;31(5): e22106.
Li R, Gao Z, Dong K, Wang H, Zhang H. Detection of carcinoembryonic antigen levels in pleural effusion and serum and their ratio for differential diagnosis of pleural effusion resulting from tuberculosis and lung cancer. Nan Fang Yi Ke Da Xue Xue Bao. 2019;39(2):175–80.
Li H, Huang L, Tang H, Zhong N, He J. Pleural fluid carcinoembryonic antigen as a biomarker for the discrimination of tumor-related pleural effusion. Clin Respir J. 2017;11(6):881–6.
Aoe K, Hiraki A, Murakami T, Murakami K, Makihata K, Takao K, Eda R, Maeda T, Sugi K, Darzynkiewicz Z, Takeyama H. Relative abundance and patterns of correlation among six cytokines in pleuralfluid measured by cytometric bead array. Int J Mol Med. 2003;12(2):193–8.
Hiraki A, Aoe K, Eda R, Maeda T, Murakami T, Sugi K, Takeyama H. Comparison of six biological markers for the diagnosis of tuberculouspleuritis. Chest. 2004;125(3):987–9.
Heffner JE. Diagnosis and management of malignant pleural effusions. Respirology. 2008;13(1):5–20.
Wu YB, Xu LL, Wang XJ, Wang Z, Zhang J, Tong ZH, Shi HZ. Diagnostic value of medical thoracoscopy in malignant pleural effusion. BMC Pulm Med. 2017;17(1):109.
Mazurnk S, Boeshnk CB, Hugo F, Eigenbrodt E. Pyruvate kinase type M2 and it role in tumor growth and spreeding. Semin Cancer Biol. 2005;15(4):300–8.
Elia S, Massoud R, Guggino G, Cristino B, Cortese C, De Massimi AR, Zenobi R. Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures. Eur J Cardiothorac Surg. 2008;33(4):723–7.
Grunnet M, Sorensen JB. Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung Cancer. 2012;76(2):138–43.
Wei F, Wei Y, Li LF, Li GL, Wang GJ. The value of B7–H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion. China J Oncol. 2017;39(7):524–7.
Dong J, Sun G, Zhu H. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion. Tumour Biol. 2016;37(3):3257–64.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.